Perception Health
- 31 profiles
- 4 categories
Featured Products
All Products & Services
The Heart Transplant Disease State Predictor is an advanced machine learning model designed to assess and predict the health status of patients undergoing heart transplantation. By analyzing a comprehensive set of patient-specific variables, this tool provides clinicians with valuable insights into potential post-transplant outcomes, facilitating informed decision-making and personalized patient care. Key Features and Functionality: - Predictive Analytics: Utilizes machine learning algorithms to forecast patient survival rates and potential complications following heart transplantation. - Comprehensive Data Analysis: Incorporates a wide range of recipient and donor variables, including functional status, hematocrit levels, albumin levels, body mass index, cardiac output, and waiting list duration, to enhance prediction accuracy. - Model Performance: Achieves high predictive accuracy, with models demonstrating an Area Under the Curve of up to 0.825, surpassing traditional risk assessment tools. Primary Value and User Benefits: The Heart Transplant Disease State Predictor addresses the critical need for precise risk stratification in heart transplant patients. By leveraging machine learning, it offers a more nuanced and individualized assessment of post-transplant mortality risk compared to conventional models. This enables healthcare providers to tailor treatment plans, optimize resource allocation, and ultimately improve patient outcomes in heart transplantation scenarios.
The Breast Cancer Disease State Predictor is a machine learning model designed to assist healthcare professionals in predicting the likelihood of breast cancer in patients. By analyzing patient data, this tool aims to provide early detection insights, thereby facilitating timely interventions and improving patient outcomes. Key Features and Functionality: - Data Analysis: Utilizes patient data to assess and predict breast cancer risk. - Machine Learning Integration: Employs advanced machine learning algorithms to enhance prediction accuracy. - Cloud-Based Deployment: Hosted on AWS, ensuring scalability and reliability. - User-Friendly Interface: Designed for seamless integration into existing healthcare systems. Primary Value and Problem Solved: The Breast Cancer Disease State Predictor addresses the critical need for early and accurate detection of breast cancer. By leveraging machine learning, it provides healthcare providers with a powerful tool to assess risk, enabling proactive patient management and potentially reducing mortality rates associated with late-stage diagnoses.
The AFIB Disease State Predictor is a sophisticated machine learning model designed to identify and predict the presence of atrial fibrillation (AFIB, the most common type of treated heart arrhythmia. By analyzing patient data, this tool aids healthcare professionals in early detection and intervention, potentially reducing the risk of complications associated with AFIB. Key Features and Functionality: - Advanced Machine Learning Algorithms: Utilizes state-of-the-art machine learning techniques to analyze complex patient data for accurate AFIB prediction. - Comprehensive Data Analysis: Processes a wide range of patient information, including age, heart rate, blood pressure, and other relevant health metrics. - Real-Time Predictions: Provides timely assessments, enabling prompt clinical decisions and interventions. - Integration with AWS Services: Seamlessly integrates with AWS infrastructure, ensuring scalability, reliability, and security. Primary Value and Problem Solved: The AFIB Disease State Predictor addresses the critical need for early and accurate detection of atrial fibrillation. By leveraging machine learning, it enhances diagnostic precision, supports proactive patient management, and ultimately contributes to improved cardiovascular health outcomes.
The Leukemia Disease State Predictor is an advanced machine learning model designed to assist healthcare professionals in accurately diagnosing and classifying various subtypes of leukemia. By analyzing comprehensive genomic data, this tool enhances the precision and efficiency of leukemia diagnosis, facilitating timely and personalized treatment plans. Key Features and Functionality: - Multi-Class Classification: Utilizes sophisticated algorithms to differentiate between multiple leukemia subtypes, ensuring precise identification. - Integration with Amazon SageMaker: Leverages the robust capabilities of Amazon SageMaker for building, training, and deploying machine learning models, streamlining the diagnostic process. - Hyperparameter Optimization: Employs SageMaker's Hyperparameter Optimization to fine-tune model parameters, achieving an accuracy of 82% in cross-validation tests. Primary Value and User Benefits: The Leukemia Disease State Predictor addresses the critical need for accurate and rapid leukemia diagnosis. By automating the analysis of whole genome sequencing (WGS and whole transcriptome sequencing (WTS data, it reduces the time and potential for human error associated with manual interpretation. This leads to more reliable diagnoses, enabling healthcare providers to implement effective treatment strategies promptly, ultimately improving patient outcomes.
The Metastatic Brain Tumor Disease State dataset is a comprehensive collection of medical imaging and clinical data focused on metastatic brain tumors. It encompasses data from 1,005 patients, including 8,003 multimodal brain MRI studies, detailed clinical follow-up information, and complete records of prescribed medications. Notably, over 2,300 images have been meticulously annotated by physicians, providing precise segmentations of metastatic tumors. This dataset stands as one of the largest and most detailed resources available for studying cranial imaging and metastatic cancer. Key Features and Functionality: - Extensive Imaging Data: Offers 8,003 multimodal brain MRI studies, facilitating in-depth analysis of metastatic brain tumors. - Comprehensive Clinical Information: Includes detailed follow-up data and complete medication records for 1,005 patients, supporting longitudinal studies. - Annotated Tumor Segmentations: Provides over 2,300 physician-annotated images with precise tumor segmentations, enhancing the accuracy of research and model training. - Open Access: Available at no cost to researchers worldwide, promoting collaborative studies and advancements in metastatic cancer research. Primary Value and User Benefits: This dataset addresses the critical need for high-quality, annotated medical imaging and clinical data in the study of metastatic brain tumors. By offering a vast and detailed collection, it enables researchers to develop and validate artificial intelligence models for tumor detection, measurement, and classification. The inclusion of longitudinal data supports the study of cancer dynamics over time, closely mirroring real-world patient experiences. Ultimately, this resource aims to accelerate the development of effective treatments and improve patient outcomes in the fight against metastatic brain cancer.
The Colorectal Cancer Disease Predictor is an advanced tool designed to assess an individual's risk of developing colorectal cancer. By analyzing various factors such as age, family history, lifestyle habits, and medical history, this predictor provides a personalized risk assessment, enabling early detection and proactive management strategies. Key Features and Functionality: - Comprehensive Risk Evaluation: Utilizes a wide range of data points, including demographic information, personal and family medical history, and lifestyle choices, to deliver an accurate risk assessment. - User-Friendly Interface: Designed for ease of use by both healthcare professionals and individuals, facilitating seamless data input and interpretation of results. - Evidence-Based Algorithm: Employs validated algorithms grounded in current medical research to ensure reliable and up-to-date risk predictions. - Actionable Insights: Provides clear recommendations for preventive measures, lifestyle modifications, and, if necessary, further diagnostic testing based on the assessed risk level. Primary Value and User Benefits: The Colorectal Cancer Disease Predictor addresses the critical need for early identification of individuals at heightened risk for colorectal cancer. By offering a personalized risk assessment, it empowers users to take proactive steps toward prevention and early intervention. Healthcare providers can leverage this tool to tailor screening schedules and preventive strategies, ultimately improving patient outcomes and reducing the incidence of advanced colorectal cancer cases.
The "Acquired Hypothyroidism Disease State" is a comprehensive dataset designed to support healthcare professionals and researchers in understanding and managing acquired hypothyroidism. This condition, characterized by insufficient thyroid hormone production, can lead to various health issues if not properly addressed. Key Features and Functionality: - Detailed Patient Profiles: The dataset includes extensive patient information, covering demographics, medical histories, and treatment outcomes, facilitating in-depth analysis and research. - Diagnostic Data: It provides laboratory results, imaging studies, and other diagnostic information essential for accurate assessment and monitoring of hypothyroidism. - Treatment Regimens: The dataset outlines various therapeutic approaches, including medication dosages, treatment durations, and patient responses, aiding in the evaluation of treatment efficacy. - Longitudinal Tracking: It offers data on patient progress over time, enabling the study of disease progression and long-term outcomes. Primary Value and Problem Solving: This dataset serves as a valuable resource for healthcare providers and researchers by offering: - Enhanced Understanding: By analyzing comprehensive patient data, users can gain insights into the epidemiology, risk factors, and clinical manifestations of acquired hypothyroidism. - Improved Patient Care: Access to detailed treatment and outcome data supports the development of evidence-based treatment protocols, leading to better patient management. - Research Advancement: The dataset facilitates clinical studies and trials, contributing to the advancement of medical knowledge and the development of new therapeutic strategies. By leveraging this dataset, users can enhance their understanding of acquired hypothyroidism, improve patient outcomes, and contribute to ongoing research in the field.
The Lymphoma Disease State Predictor is an advanced machine learning model designed to assess and predict the progression of lymphoma by analyzing patient-specific data. This tool leverages deep learning algorithms to evaluate various clinical and histological parameters, providing healthcare professionals with a risk score that indicates the likelihood of disease progression. By integrating this predictor into clinical workflows, medical practitioners can make more informed decisions regarding treatment strategies, potentially improving patient outcomes. Key Features and Functionality: - Risk Assessment: Generates a histologic risk score (HRS by analyzing whole slide images from hematoxylin and eosin-stained lymphoma tissues collected prior to therapy. - Deep Learning Integration: Utilizes a convolutional neural network (CNN foundation model, pre-trained via self-supervised learning on a diverse set of over 1 million whole-slide image tiles from various benign and malignant tissue types. - Survival Prediction: Employs a regression head trained using supervised learning to optimize the Cox partial likelihood, using progression-free survival (PFS as a label, thereby predicting the risk of disease progression. - Clinical Validation: Tested on independent cohorts, including patients enrolled in Phase III clinical trials, to ensure accuracy and reliability in real-world scenarios. Primary Value and Problem Solved: The Lymphoma Disease State Predictor addresses the critical need for precise and individualized risk assessment in lymphoma patients. Traditional methods of evaluating disease progression often rely on generalized criteria, which may not capture the nuances of individual cases. By providing a personalized risk score based on deep learning analysis of histological data, this tool enables clinicians to tailor treatment plans more effectively, potentially enhancing patient survival rates and optimizing resource allocation in healthcare settings.
Perception Health Reviews
Dr. Pratik M.
Head HSEF & JT.General ManagerExcellent in Health Management
Jhemar M.
Asistente de Servicio al Pasajero en Aeropuerto Internacional de Tocumen Panamá
Verified User in Staffing and Recruiting
A short review
About
What is Perception Health?
Perception Health is a healthcare technology company that specializes in utilizing advanced data analytics to enhance decision-making for healthcare providers and organizations. Their services focus on improving patient outcomes, optimizing resource utilization, and driving strategic growth through actionable insights derived from healthcare data. By leveraging predictive analytics and visual data presentations, Perception Health aids in identifying trends and opportunities within healthcare systems.